Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer.
Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer.
复制标题
DOI:
10.1016/j.lungcan.2014.04.013
复制
发表时间:
2014-08
期刊:
影响因子:
5.3
通讯作者:
Xiaolong Qi;Wang Ma;Sen Li;Caicun Zhou
中科院分区:
文献类型:
--
作者:
Xiaolong Qi;Wang Ma;Sen Li;Caicun Zhou